Reagents and consumables

Ended Awarded

Contract number
75N91024F00005
Awardee
Awarding agency
Obligated
$11,584

Award facts

Contract value 100% obligated
$11,583.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Indianapolis, IN 46250, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $11,583.72 firm fixed price delivery order contract to Roche Diagnostics Corporation. The contract is for reagents and consumables to be delivered to a place of performance in Castleton, Indiana. The contract period of performance runs from December 21, 2023 through January 21, 2024. No major subcontractors or set aside designations were identified. The award provides products to support the National Cancer Institute's research efforts in advancing cancer prevention, diagnosis, and treatment.

Quick answers

Who was awarded contract 75N91024F00005?

75N91024F00005 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on December 21, 2023.

How much is contract 75N91024F00005 worth?

The government has obligated $11,584 on 75N91024F00005.

Is contract 75N91024F00005 an order under another contract?

Yes. 75N91024F00005 is a delivery order under 75N91019D00038, an indefinite delivery contract.

Was contract 75N91024F00005 competed?

The extent of competition for 75N91024F00005 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award